10-Q Filing

AEHR TEST SYSTEMS CIK: 1040470 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001654954-22-004928`
Period End Date	20220228
Filing Date	20220413
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	aehr_10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 72 Cash Flow Statement 54 Stockholders Equity 30 Comprehensive Income 24

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$14.15M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.73M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	26.91M	shares	Point-in-time
Inventories	`InventoryNet`	$8.85M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$551.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$559.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	75.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$19.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$55.27M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.73M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	26.91M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$776.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$677.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.09M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$1.61M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$214.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$198.00K	USD	Point-in-time
Total assets	`Assets`	$21.66M	USD	Point-in-time
Total assets	`Assets`	$57.35M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.58M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.31M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.16M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.54M	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$778.00K	USD	Point-in-time
Operating lease liabilities, short-term	`OperatingLeaseLiabilityCurrent`	$737.00K	USD	Point-in-time
Customer deposits and deferred revenue, short-term	`CustomerDepositsAndDeferredRevenueShortTerm`	$6.20M	USD	Point-in-time
Customer deposits and deferred revenue, short-term	`CustomerDepositsAndDeferredRevenueShortTerm`	$189.00K	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$1.40M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	-	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.68M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.82M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.06M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$1.01M	USD	Point-in-time
Operating lease liabilities, long-term	`OperatingLeaseLiabilityNoncurrent`	$415.00K	USD	Point-in-time
Deferred revenue, long-term	`DeferredRevenueNoncurrent`	$90.00K	USD	Point-in-time
Deferred revenue, long-term	`DeferredRevenueNoncurrent`	$99.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$49.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$45.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$13.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.22M	USD	Point-in-time
Common stock, $0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 26,914 shares and 23,725 shares at February 28, 2022 and May 31, 2021, respectively	`CommonStockValue`	$237.00K	USD	Point-in-time
Common stock, $0.01 par value: Authorized: 75,000 shares; Issued and outstanding: 26,914 shares and 23,725 shares at February 28, 2022 and May 31, 2021, respectively	`CommonStockValue`	$269.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$87.55M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$116.51M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.20M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$8.54M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-28.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-131.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-72.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.31M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$40.86M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$11.45M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$43.99M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$21.66M	USD	Point-in-time
Total liabilities and shareholders' equity	`LiabilitiesAndStockholdersEquity`	$57.35M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net sales	`Revenues`	$15.28M	USD	1 Quarter
Net sales	`Revenues`	$5.27M	USD	1 Quarter
Net sales	`Revenues`	$8.96M	USD	3 Qtrs
Net sales	`Revenues`	$30.54M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$3.37M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$17.34M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$8.89M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$6.46M	USD	3 Qtrs
Gross profit	`GrossProfit`	$6.40M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.89M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.50M	USD	3 Qtrs
Gross profit	`GrossProfit`	$13.20M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$7.05M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.61M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.64M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$4.66M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.62M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.16M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$903.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$11.22M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$7.28M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$4.14M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.55M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$1.98M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-652.00K	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$2.26M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-4.78M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$1.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-10.00K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-35.00K	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNet`	$-9.00K	USD	3 Qtrs
Net gain from dissolution of Aehr Test Systems Japan	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Net gain from dissolution of Aehr Test Systems Japan	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Net gain from dissolution of Aehr Test Systems Japan	`GainLossOnSaleOfBusiness`	$2.19M	USD	3 Qtrs
Net gain from dissolution of Aehr Test Systems Japan	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Gain from forgiveness of PPP loan	`GainFromForgivenessOfPppLoan`	-	USD	1 Quarter
Gain from forgiveness of PPP loan	`GainFromForgivenessOfPppLoan`	-	USD	3 Qtrs
Gain from forgiveness of PPP loan	`GainFromForgivenessOfPppLoan`	-	USD	1 Quarter
Gain from forgiveness of PPP loan	`GainFromForgivenessOfPppLoan`	$1.70M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-39.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$68.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-139.00K	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$10.00K	USD	1 Quarter
Income (loss) before income tax (expense) benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.27M	USD	1 Quarter
Income (loss) before income tax (expense) benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.74M	USD	3 Qtrs
Income (loss) before income tax (expense) benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-701.00K	USD	1 Quarter
Income (loss) before income tax (expense) benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.77M	USD	3 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$34.00K	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$24.00K	USD	1 Quarter
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$-177.00K	USD	3 Qtrs
Income tax (expense) benefit	`IncomeTaxExpenseBenefit`	$81.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-735.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.66M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.59M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$2.24M	USD	1 Quarter
Earnings Per Share Basic	`EarningsPerShareBasic`	$0.14	USD	3 Qtrs
Earnings Per Share Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Earnings Per Share Basic	`EarningsPerShareBasic`	$-0.03	USD	1 Quarter
Earnings Per Share Basic	`EarningsPerShareBasic`	$-0.11	USD	3 Qtrs
EarningsPerShareDiluted	`EarningsPerShareDiluted`	$-0.03	USD	1 Quarter
EarningsPerShareDiluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
EarningsPerShareDiluted	`EarningsPerShareDiluted`	$0.13	USD	3 Qtrs
EarningsPerShareDiluted	`EarningsPerShareDiluted`	$-0.11	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.39M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	26.87M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	23.52M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	25.68M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	28.85M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.51M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.39M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	23.52M	shares	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$3.66M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-2.59M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$2.19M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$798.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$226.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$239.00K	USD	3 Qtrs
Net gain from dissolution of Aehr Test Systems Japan	`NetGainFromDissolutionOfAehrTestSystemsJapan`	$-2.19M	USD	3 Qtrs
Net gain from dissolution of Aehr Test Systems Japan	`NetGainFromDissolutionOfAehrTestSystemsJapan`	-	USD	3 Qtrs
Income tax benefit related to dissolution of Aehr Test Systems Japan	`IncomeTaxBenefitRelatedToDissolutionOfSubsidiary`	-	USD	3 Qtrs
Income tax benefit related to dissolution of Aehr Test Systems Japan	`IncomeTaxBenefitRelatedToDissolutionOfSubsidiary`	$-215.00K	USD	3 Qtrs
Gain from forgiveness of PPP loan	`DebtInstrumentDecreaseForgiveness`	-	USD	3 Qtrs
Gain from forgiveness of PPP loan	`DebtInstrumentDecreaseForgiveness`	$1.70M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.06M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.45M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$349.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$5.45M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$45.00K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$28.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$444.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$78.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$375.00K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$179.00K	USD	3 Qtrs
Customer deposits and deferred revenue	`IncreaseDecreaseInCustomerDepositsAndDeferredRevenue`	$475.00K	USD	3 Qtrs
Customer deposits and deferred revenue	`IncreaseDecreaseInCustomerDepositsAndDeferredRevenue`	$6.00M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$43.00K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$18.00K	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$3.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.27M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.51M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$218.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$205.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-205.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-218.00K	USD	3 Qtrs
Line of credit (repayments) borrowings, net	`ProceedsFromLinesOfCredit`	$1.40M	USD	3 Qtrs
Line of credit (repayments) borrowings, net	`ProceedsFromLinesOfCredit`	$1.40M	USD	3 Qtrs
Proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards	`ProceedsFromIssuanceOfCommonStock`	$483.00K	USD	3 Qtrs
Proceeds from issuance of common stock under employee plans, net of taxes paid related to share settlement of equity awards	`ProceedsFromIssuanceOfCommonStock`	$2.77M	USD	3 Qtrs
Proceeds from issuance of common stock from public offering, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$24.03M	USD	3 Qtrs
Proceeds from issuance of common stock from public offering, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$25.40M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.88M	USD	3 Qtrs
Effect of exchange rates on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-19.00K	USD	3 Qtrs
Effect of exchange rates on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$138.00K	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalent and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-695.00K	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalent and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$27.44M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.66M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.82M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$32.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.66M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.82M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$32.10M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.06M	USD	Point-in-time
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.79M	USD	Point-in-time
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.48M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$40.86M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$11.45M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$43.99M	USD	Point-in-time
Issuance of common stock under employee plans, amount	`StockIssuedDuringPeriodValueShareBasedCompensation`	$118.00K	USD	1 Quarter
Issuance of common stock under employee plans, amount	`StockIssuedDuringPeriodValueShareBasedCompensation`	$483.00K	USD	3 Qtrs
Issuance of common stock under employee plans, amount	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.77M	USD	3 Qtrs
Issuance of common stock under employee plans, amount	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.19M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$271.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$798.00K	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$880.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-735.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.66M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.59M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$2.24M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-103.00K	USD	3 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-23.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$39.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$143.00K	USD	3 Qtrs
Reclassification of cumulative translation adjustment as a result of dissolution of Aehr Test Systems Japan	`ReclassificationOfCumulativeTranslationAdjustmentAsAResultOfDissolutionOfAehrTestSystemsJapan`	$-2.40M	USD	3 Qtrs
Proceeds from public offerings, net of issuance costs, amount	`ProceedsFromPublicOfferingsNetOfIssuanceCostsAmount`	$24.03M	USD	3 Qtrs
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.06M	USD	Point-in-time
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.79M	USD	Point-in-time
Balance, amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$10.48M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$40.86M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$11.45M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$43.99M	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-735.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.66M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-2.59M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$2.24M	USD	1 Quarter
Net change in cumulative translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$143.00K	USD	3 Qtrs
Net change in cumulative translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-23.00K	USD	1 Quarter
Net change in cumulative translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$39.00K	USD	1 Quarter
Net change in cumulative translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-103.00K	USD	3 Qtrs
Reclassification of cumulative translation adjustment as a result of dissolution of Aehr Test Systems Japan	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	$2.40M	USD	3 Qtrs
Reclassification of cumulative translation adjustment as a result of dissolution of Aehr Test Systems Japan	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	-	USD	1 Quarter
Reclassification of cumulative translation adjustment as a result of dissolution of Aehr Test Systems Japan	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	-	USD	1 Quarter
Reclassification of cumulative translation adjustment as a result of dissolution of Aehr Test Systems Japan	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax`	-	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-696.00K	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.85M	USD	3 Qtrs
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.22M	USD	1 Quarter
Total comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.55M	USD	3 Qtrs
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$21.00K	USD	3 Qtrs
Comprehensive income (loss), attributable to Aehr Test Systems	`ComprehensiveIncomeNetOfTax`	$2.22M	USD	1 Quarter
Comprehensive income (loss), attributable to Aehr Test Systems	`ComprehensiveIncomeNetOfTax`	$-696.00K	USD	1 Quarter
Comprehensive income (loss), attributable to Aehr Test Systems	`ComprehensiveIncomeNetOfTax`	$3.55M	USD	3 Qtrs
Comprehensive income (loss), attributable to Aehr Test Systems	`ComprehensiveIncomeNetOfTax`	$-4.87M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.